Mr Darwin A Castor, CRNAP | |
181 Corliss Lane, Ucvh, Colebrook, NH 03576 | |
(603) 237-8228 | |
Not Available |
Full Name | Mr Darwin A Castor |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 181 Corliss Lane, Colebrook, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053561001 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 034689-23-11 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Darwin A Castor, CRNAP 67 Bob House Rd, Holderness, NH 03245-5500 Ph: (603) 968-9627 | Mr Darwin A Castor, CRNAP 181 Corliss Lane, Ucvh, Colebrook, NH 03576 Ph: (603) 237-8228 |
News Archive
Guardant Health today announced that five abstracts submitted by the University of California, San Francisco; University of California, San Diego; and MD Anderson highlighting the performance and clinical utility of Guardant360 have been accepted for oral and poster presentations at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, May 29-June 2.
The holiday season can be particularly over-stimulating for young children, what with more pressure-packed traveling, shopping and even church-going. Boston University child psychologist Dr. Jonathan Comer offers parents these helpful tips on handling those unwanted tantrums and meltdowns by their kids - or by someone else's.
Despite significant investment in health information technology such as computerized health records and clinical decision support, leveraging the technology to improve the quality of care will require significant and sustained effort by health systems, according to a new RAND Corporation study.
Alkermes plc (NASDAQ: ALKS) today announced positive preliminary topline results from a phase 2 study of ALKS 5461, its novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.
› Verified 9 days ago